{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:43:14Z","timestamp":1791567794888,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We recently established an external quality assessment (EQA) scheme for next-generation sequencing (NGS) diagnostics in rare neurological disorders (RND) in collaboration with the EMQN. The first assessment rounds revealed limitations and variability in the quality and completeness of genetic testing reports. To improve and harmonize reporting in NGS-based diagnostics for RND, we identified 28 topics requiring recommendations based on EQA findings. These topics were grouped into four areas: clinical information, interpretation, methodology, and reporting. A team of 31 experts with relevant expertise was formed. Using an adapted Delphi approach, two rounds of surveys were conducted to prioritize the topics. Subsequently, area-specific expert groups met to formulate recommendations, followed by a final approval round using the five-finger consensus method involving all experts. In both Delphi rounds, all topics were rated as either very important (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200912) or important (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200916), and all were advanced for recommendation development. Consensus recommendations were achieved for 27 of the 28 topics. These include guidance on gene panel composition and updating, addressing disease-specific limitations of NGS (e.g., repeat expansion disorders), defining minimal quality parameters, and promoting sharing of variant interpretations. Each recommendation is supported by real-world examples. Due to differences in national healthcare frameworks and policies, consensus could not be reached regarding which patients should or should not undergo NGS testing. The dissemination of these recommendations is expected to improve the quality of genetic testing and reporting in RND diagnostics, promoting harmonization across laboratories and enabling easier comparison and interpretation of genetic testing reports.\n                  <\/jats:p>","DOI":"10.1038\/s41431-026-02198-4","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:20:02Z","timestamp":1785241202000},"page":"1503-1512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Consensus recommendations for next-generation sequencing-based genetic testing in Rare Neurological diseases"],"prefix":"10.1038","volume":"34","author":[{"given":"Ale\u0161","family":"Maver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5121-1460","authenticated-orcid":false,"given":"Katja","family":"Lohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena-Marie","family":"Urbanczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astri","family":"Arnesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Bari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9414-4555","authenticated-orcid":false,"given":"Peter","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash P.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1657-7368","authenticated-orcid":false,"given":"Sylvia","family":"Boesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran","family":"Borove\u010dki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zih-Hua","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6033-4836","authenticated-orcid":false,"given":"Tobias B.","family":"Haack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2866-7777","authenticated-orcid":false,"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3939-9739","authenticated-orcid":false,"given":"Milena","family":"Jankovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6480-1892","authenticated-orcid":false,"given":"Erik-Jan","family":"Kamsteeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4156-1464","authenticated-orcid":false,"given":"Deborah","family":"Mascalzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9350-1864","authenticated-orcid":false,"given":"Maria Judit","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"M\u00fcnchau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8055-5329","authenticated-orcid":false,"given":"Kornelia","family":"Neveling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Novakovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7824-4978","authenticated-orcid":false,"given":"Borut","family":"Peterlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5739","authenticated-orcid":false,"given":"Nika","family":"Schuermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1649-1495","authenticated-orcid":false,"given":"Katie","family":"Shiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6552-8362","authenticated-orcid":false,"given":"Marc","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5783-571X","authenticated-orcid":false,"given":"Marina A. J.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6470-5497","authenticated-orcid":false,"given":"Lisenka E. L. M.","family":"Vissers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0834-7426","authenticated-orcid":false,"given":"Victoria","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9803-7183","authenticated-orcid":false,"given":"Holm","family":"Graessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the European Reference Network for Rare Neurological Disorders (ERN-RND)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"2198_CR1","doi-asserted-by":"publisher","unstructured":"Penn D, Amir Y, David GB, Kurolap A, Barel D, Hamiel U, et al. High Genetic Diagnostic Yield for Patients with Rare Movement Disorders at a Single-Center Neurogenetics Clinic. Mov Disord Clin Pract. 2025;5. https:\/\/doi.org\/10.1002\/mdc3.70145.","DOI":"10.1002\/mdc3.70145"},{"key":"2198_CR2","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.3390\/biomedicines12122673","volume":"12","author":"L Marsili","year":"2024","unstructured":"Marsili L, Duque KR, Abanto J, Chinchihualpa Paredes NO, Duker AP, Collins K, et al. Studying Rare Movement Disorders: From Whole-Exome Sequencing to New Diagnostic and Therapeutic Approaches in a Modern Genetic Clinic. Biomedicines. 2024;12:2673. https:\/\/doi.org\/10.3390\/biomedicines12122673.","journal-title":"Biomedicines"},{"key":"2198_CR3","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41431-021-00901-1","volume":"29","author":"R Sch\u00fcle","year":"2021","unstructured":"Sch\u00fcle R, Timmann D, Erasmus CE, Reichbauer J, Wayand M, Sch\u00f6ls L, et al. Solve-RD-DITF-RND Solving unsolved rare neurological diseases-a Solve-RD viewpoint. Eur J Hum Genet EJHG. 2021;29:1332\u20136. https:\/\/doi.org\/10.1038\/s41431-021-00901-1.","journal-title":"Eur J Hum Genet EJHG"},{"key":"2198_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1304520","volume":"14","author":"A Marouane","year":"2023","unstructured":"Marouane A, Neveling K, Deden AC, van den Heuvel S, Zafeiropoulou D, Castelein S, et al. Lessons learned from rapid exome sequencing for 575 critically ill patients across the broad spectrum of rare disease. Front Genet. 2023;14:1304520. https:\/\/doi.org\/10.3389\/fgene.2023.1304520.","journal-title":"Front Genet"},{"key":"2198_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01301-y","volume":"16","author":"G Schobers","year":"2024","unstructured":"Schobers G, Derks R, den Ouden A, Swinkels H, van Reeuwijk J, Bosgoed E, et al. Genome sequencing as a generic diagnostic strategy for rare disease. Genome Med. 2024;16:32. https:\/\/doi.org\/10.1186\/s13073-024-01301-y.","journal-title":"Genome Med"},{"key":"2198_CR6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/humu.24360","volume":"43","author":"J Corominas","year":"2022","unstructured":"Corominas J, Smeekens SP, Nelen MR, Yntema HG, Kamsteeg EJ, Pfundt R, et al. Clinical exome sequencing-Mistakes and caveats. Hum Mutat. 2022;43:1041\u201355. https:\/\/doi.org\/10.1002\/humu.24360.","journal-title":"Hum Mutat"},{"key":"2198_CR7","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/s41431-024-01639-2","volume":"32","author":"A Maver","year":"2024","unstructured":"Maver A, Lohmann K, Borove\u010dki F, Wolstenholme N, Taylor RL, Spielmann M, et al. Quality assurance for next-generation sequencing diagnostics of rare neurological diseases in the European Reference Network. Eur J Hum Genet. 2024;32:1014\u201321. https:\/\/doi.org\/10.1038\/s41431-024-01639-2.","journal-title":"Eur J Hum Genet"},{"key":"2198_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.616569","volume":"11","author":"C Reinhard","year":"2020","unstructured":"Reinhard C, Bachoud-L\u00e9vi AC, B\u00e4umer T, Bertini E, Brunelle A, Buizer AI, et al. The European Reference Network for Rare Neurological Diseases. Front Neurol. 2020;11:616569. https:\/\/doi.org\/10.3389\/fneur.2020.616569.","journal-title":"Front Neurol"},{"key":"2198_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ejhg.2015.226","volume":"24","author":"G Matthijs","year":"2016","unstructured":"Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, et al. Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet. 2016;24:2\u20135. https:\/\/doi.org\/10.1038\/ejhg.2015.226.","journal-title":"Eur J Hum Genet"},{"key":"2198_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-022-00295-z","volume":"7","author":"CA Austin-Tse","year":"2022","unstructured":"Austin-Tse CA, Jobanputra V, Perry DL, Bick D, Taft RJ, Venner E, et al. Best practices for the interpretation and reporting of clinical whole genome sequencing. Npj Genom Med. 2022;7:27. https:\/\/doi.org\/10.1038\/s41525-022-00295-z.","journal-title":"Npj Genom Med"},{"key":"2198_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41431-022-01113-x","volume":"30","author":"E Souche","year":"2022","unstructured":"Souche E, Beltran S, Brosens E, Belmont JW, Fossum M, Riess O, et al. Recommendations for whole genome sequencing in diagnostics for rare diseases. Eur J Hum Genet. 2022;30:9. https:\/\/doi.org\/10.1038\/s41431-022-01113-x.","journal-title":"Eur J Hum Genet"},{"key":"2198_CR12","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/acn3.70100","volume":"12","author":"M Thomsen","year":"2025","unstructured":"Thomsen M, Ott F, Loens S, Kilic-Berkmen G, Tan AH, Lim SY, et al. Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large-Scale Exome Sequencing. Ann Clin Transl Neurol. 2025;12:1648\u201359. https:\/\/doi.org\/10.1002\/acn3.70100.","journal-title":"Ann Clin Transl Neurol"},{"key":"2198_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1353\/cpr.2011.0022","volume":"5","author":"C Nicolaidis","year":"2011","unstructured":"Nicolaidis C, Raymaker D, McDonald K, Dern S, Ashkenazy E, Boisclair C, et al. Collaboration Strategies in Nontraditional Community-Based Participatory Research Partnerships: Lessons From an Academic\u2013Community Partnership With Autistic Self-Advocates. Prog Commun Health Partnersh. 2011;5:143\u201350. https:\/\/doi.org\/10.1353\/cpr.2011.0022.","journal-title":"Prog Commun Health Partnersh"},{"key":"2198_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5334\/tohm.835","volume":"14","author":"D Yeow","year":"2024","unstructured":"Yeow D, Rudaks LI, Siow SF, Davis RL, Kumar KR. Genetic Testing of Movements Disorders: A Review of Clinical Utility. Tremor Hyperk Mov N Y N. 2024;14:2. https:\/\/doi.org\/10.5334\/tohm.835.","journal-title":"Tremor Hyperk Mov N Y N"},{"key":"2198_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/WCO.0000000000001381","volume":"38","author":"D Yeow","year":"2025","unstructured":"Yeow D, Rudaks LI, Kumar KR. Barriers to clinical genetic testing in movement disorders. Curr Opin Neurol. 2025;38:355\u201360. https:\/\/doi.org\/10.1097\/WCO.0000000000001381.","journal-title":"Curr Opin Neurol"},{"key":"2198_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S1474-4422(24)00121-2","volume":"23","author":"EK Gustavsson","year":"2024","unstructured":"Gustavsson EK, Follett J, Trinh J, Barodia SK, Real R, Liu Z, et al. RAB32 Ser71Arg in autosomal dominant Parkinson\u2019s disease: linkage, association, and functional analyses. Lancet Neurol. 2024;23:603\u201314. https:\/\/doi.org\/10.1016\/S1474-4422(24)00121-2.","journal-title":"Lancet Neurol"},{"key":"2198_CR17","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s41588-024-01787-7","volume":"56","author":"PJ Hop","year":"2024","unstructured":"Hop PJ, Lai D, Keagle PJ, Baron DM, Kenna BJ, Kooyman M, et al. Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson\u2019s disease. Nat Genet. 2024;56:1371\u20136. https:\/\/doi.org\/10.1038\/s41588-024-01787-7.","journal-title":"Nat Genet"},{"key":"2198_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-023-00455-0","volume":"56","author":"NM Ryan","year":"2023","unstructured":"Ryan NM, Corvin A. Investigating the dark-side of the genome: a barrier to human disease variant discovery? Biol Res. 2023;56:42. https:\/\/doi.org\/10.1186\/s40659-023-00455-0.","journal-title":"Biol Res"},{"key":"2198_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1474-4422(21)00462-2","volume":"21","author":"K Iba\u00f1ez","year":"2022","unstructured":"Iba\u00f1ez K, Polke J, Hagelstrom RT, Dolzhenko E, Pasko D, Thomas ERA, et al. Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study. Lancet Neurol. 2022;21:234\u201345. https:\/\/doi.org\/10.1016\/S1474-4422(21)00462-2.","journal-title":"Lancet Neurol"},{"key":"2198_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ajmg.a.62500","volume":"188","author":"E Bartlett","year":"2022","unstructured":"Bartlett E, Archibald AD, Francis D, Ling L, Thomas R, Chandler G, et al. Paternal retraction of a fragile X allele to normal size, showing normal function over two generations. Am J Med Genet A. 2022;188:304\u20139. https:\/\/doi.org\/10.1002\/ajmg.a.62500.","journal-title":"Am J Med Genet A"},{"key":"2198_CR21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/mds.28452","volume":"36","author":"C Beetz","year":"2021","unstructured":"Beetz C, Westenberger A, Al-Ali R, Ameziane N, Alhashmi N, Boustany R, et al. LRRK2 Loss-of-Function Variants in Patients with Rare Diseases: No Evidence for a Phenotypic Impact. Mov Disord. 2021;36:1029\u201331. https:\/\/doi.org\/10.1002\/mds.28452.","journal-title":"Mov Disord"},{"key":"2198_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-025-00881-9","volume":"11","author":"C Kr\u00fcger","year":"2025","unstructured":"Kr\u00fcger C, Lim SY, Buhrmann A, Fahrig FL, Gabbert C, Bahr N, et al. Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson\u00b4s disease. NPJ Park Dis. 2025;11:30. https:\/\/doi.org\/10.1038\/s41531-025-00881-9.","journal-title":"NPJ Park Dis"},{"key":"2198_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/mds.30072","volume":"40","author":"S Ramakrishnan","year":"2025","unstructured":"Ramakrishnan S, Mohan N, Dong Z, Liu M, Qiang L. Unraveling Isoform Complexity: The Roles of M1- and M87-Spastin in Spastic Paraplegia 4 (SPG4). Mov Disord Off J. Mov Disord Soc. 2025;40:420\u201330. https:\/\/doi.org\/10.1002\/mds.30072.","journal-title":"Mov Disord Soc"},{"key":"2198_CR24","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3390\/genes14040822","volume":"14","author":"MG Pauly","year":"2023","unstructured":"Pauly MG, Korenke GC, Diaw SH, Gr\u00f6zinger A, Cazurro-Guti\u00e9rrez A, P\u00e9rez-Due\u00f1as B, et al. The Expanding Phenotypical Spectrum of WARS2-Related Disorder: Four Novel Cases with a Common Recurrent Variant. Genes. 2023;14:822. https:\/\/doi.org\/10.3390\/genes14040822.","journal-title":"Genes"},{"key":"2198_CR25","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/ana.25220","volume":"83","author":"E Seong","year":"2018","unstructured":"Seong E, Insolera R, Dulovic M, Kamsteeg EJ, Trinh J, Br\u00fcggemann N, et al. Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects. Ann Neurol. 2018;83:1075\u201388. https:\/\/doi.org\/10.1002\/ana.25220.","journal-title":"Ann Neurol"},{"key":"2198_CR26","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s41431-022-01091-0","volume":"30","author":"ZC Deans","year":"2022","unstructured":"Deans ZC, Ahn JW, Carreira IM, Dequeker E, Henderson M, Lovrecic L, et al. Recommendations for reporting results of diagnostic genomic testing. Eur J Hum Genet. 2022;30:1011\u20136. https:\/\/doi.org\/10.1038\/s41431-022-01091-0.","journal-title":"Eur J Hum Genet"},{"key":"2198_CR27","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/ejhg.2016.63","volume":"24","author":"G Matthijs","year":"2016","unstructured":"Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, et al. Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet. 2016;24:1515. https:\/\/doi.org\/10.1038\/ejhg.2016.63.","journal-title":"Eur J Hum Genet"},{"key":"2198_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/mds.28874","volume":"37","author":"A Weissbach","year":"2022","unstructured":"Weissbach A, Pauly MG, Herzog R, Hahn L, Halmans S, Hamami F, et al. Relationship of Genotype, Phenotype, and Treatment in Dopa-Responsive Dystonia: MDSGene Review. Mov Disord J Mov Disord Soc. 2022;37:237\u201352. https:\/\/doi.org\/10.1002\/mds.28874.","journal-title":"Mov Disord J Mov Disord Soc"},{"key":"2198_CR29","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41591-024-03420-w","volume":"31","author":"S Laurie","year":"2025","unstructured":"Laurie S, Steyaert W, de Boer E, Polavarapu K, Schuermans N, Sommer AK, et al. Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Nat Med. 2025;31:478\u201389. https:\/\/doi.org\/10.1038\/s41591-024-03420-w.","journal-title":"Nat Med"},{"key":"2198_CR30","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.ajhg.2024.08.012","volume":"111","author":"S Majeed","year":"2024","unstructured":"Majeed S, Johnston C, Saeedi S, Mighton C, Rokoszak V, Abbasi I, et al. International policies guiding the selection, analysis, and clinical management of secondary findings from genomic sequencing: A systematic review. Am J Hum Genet. 2024;111:2079\u201393. https:\/\/doi.org\/10.1016\/j.ajhg.2024.08.012.","journal-title":"Am J Hum Genet"},{"key":"2198_CR31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ejmg.2017.07.016","volume":"60","author":"DF Vears","year":"2017","unstructured":"Vears DF, S\u00e9n\u00e9cal K, Borry P. Reporting practices for variants of uncertain significance from next generation sequencing technologies. Eur J Med Genet. 2017;60:553\u20138. https:\/\/doi.org\/10.1016\/j.ejmg.2017.07.016.","journal-title":"Eur J Med Genet"},{"key":"2198_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.64012","volume":"197","author":"CG Brown","year":"2025","unstructured":"Brown CG, Bower M, Schomaker M, Goldstein J, Jarnes J, Whitley CB, et al. Detecting the Difficult: An Intronic NPC1 Variant Hiding in Plain Sight. Am J Med Genet A. 2025;197:e64012. https:\/\/doi.org\/10.1002\/ajmg.a.64012.","journal-title":"Am J Med Genet A"},{"key":"2198_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0844-0","volume":"13","author":"M Pineda","year":"2018","unstructured":"Pineda M, Walterfang M, Patterson MC. Miglustat in Niemann-Pick disease type C patients: a review. Orphanet J Rare Dis. 2018;13:140. https:\/\/doi.org\/10.1186\/s13023-018-0844-0.","journal-title":"Orphanet J Rare Dis"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02198-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:57:52Z","timestamp":1791017872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02198-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2198"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02198-4","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Peter Bauer is an employee and shareholder of Centogene GmbH. Sylvia Boesch has consultancy relationships with VICO Therapeutics, Reata Pharmaceuticals, and Biogen; serves on advisory boards for Biogen, Reata Pharmaceuticals, and Biohaven; and has received honoraria from Ipsen Pharma, Merz Pharma, Reata Pharmaceuticals, and Biogen. All other authors report no conflicts of interest pertaining to this work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}